These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 9750003)

  • 1. Riluzole, a glutamate release inhibitor, and motor behavior.
    Kretschmer BD; Kratzer U; Schmidt WJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):181-90. PubMed ID: 9750003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the mesolimbic dopamine system by glutamate: role of NMDA receptors.
    Kretschmer BD
    J Neurochem; 1999 Aug; 73(2):839-48. PubMed ID: 10428083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine-glutamate interplay in the ventral striatum modulates spatial learning in a receptor subtype-dependent manner.
    Coccurello R; Oliverio A; Mele A
    Neuropsychopharmacology; 2012 Apr; 37(5):1122-33. PubMed ID: 22218092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor stimulation following bilateral injection of the group-I metabotropic glutamate receptor agonist into the dorsal striatum of rats: evidence against dependence on ionotropic glutamate receptors.
    Mao L; Wang JQ
    Psychopharmacology (Berl); 2000 Mar; 148(4):367-73. PubMed ID: 10928309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some central effects of GYKI 52466, a non-competitive AMPA receptor antagonist.
    Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
    Pol J Pharmacol; 1995; 47(6):501-7. PubMed ID: 8868372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of NMDA-stimulated [14C]GABA and [3H]acetylcholine release by striatal glutamate and dopamine receptors.
    Hanania T; Johnson KM
    Brain Res; 1999 Oct; 844(1-2):106-17. PubMed ID: 10536266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of decahydroisoquinoline-3-carboxylic acid monohydrate, a novel AMPA receptor antagonist, on glutamate-induced CA2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons.
    Liljequist S; Cebers G; Kalda A
    Biochem Pharmacol; 1995 Nov; 50(11):1761-74. PubMed ID: 8615854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine-independent locomotion following blockade of N-methyl-D-aspartate receptors in the ventral tegmental area.
    Cornish JL; Nakamura M; Kalivas PW
    J Pharmacol Exp Ther; 2001 Jul; 298(1):226-33. PubMed ID: 11408546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of AMPA receptor antagonists on dopamine-mediated behaviors in mice.
    Vanover KE
    Psychopharmacology (Berl); 1998 Mar; 136(2):123-31. PubMed ID: 9551768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine.
    Hauber W; Andersen R
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):486-90. PubMed ID: 8114947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Riluzole attenuates the effects of chemoconvulsants acting on glutamatergic and GABAergic neurotransmission in the planarian Dugesia tigrina.
    Ramakrishnan L; Dalhoff Z; Fettig SL; Eggerichs MR; Nelson BE; Shrestha B; Elshikh AH; Karki P
    Eur J Pharmacol; 2013 Oct; 718(1-3):493-501. PubMed ID: 23872399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
    Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
    Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excitatory amino acids and synaptic transmission in embryonic rat brainstem motoneurons in organotypic culture.
    Launey T; Ivanov A; Kapus G; Ferrand N; Tarnawa I; Gueritaud JP
    Eur J Neurosci; 1999 Apr; 11(4):1324-34. PubMed ID: 10103128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-NMDA receptor-mediated mechanisms are involved in levodopa-induced motor response alterations in Parkinsonian rats.
    Marin C; Jimenez A; Bonastre M; Chase TN; Tolosa E
    Synapse; 2000 Jun; 36(4):267-74. PubMed ID: 10819904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD.
    Bibbiani F; Oh JD; Kielaite A; Collins MA; Smith C; Chase TN
    Exp Neurol; 2005 Dec; 196(2):422-9. PubMed ID: 16203001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus can modulate haloperidol-induced catalepsy.
    Melo LL; Santos P; Medeiros P; Mello RO; Ferrari EA; Brandão ML; Maisonnette SS; Francisco A; Coimbra NC
    Brain Res; 2010 Aug; 1349():41-7. PubMed ID: 20558148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of striatal group II metabotropic glutamate receptors has a differential effect on dopamine-D1 and -D2 receptor antagonist-induced hypokinesia in the rat.
    Kronthaler UO; Schmidt WJ
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):289-97. PubMed ID: 10731042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairments of movement initiation and execution induced by a blockade of dopamine D1 or D2 receptors are reversed by a blockade of N-methyl-D-aspartate receptors.
    Hauber W
    Neuroscience; 1996 Jul; 73(1):121-30. PubMed ID: 8783236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist.
    Tzschentke TM; Schmidt WJ
    Eur J Pharmacol; 1996 Jan; 295(2-3):137-46. PubMed ID: 8720577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intracerebral administration of NMDA and AMPA on dopamine and glutamate release in the ventral pallidum and on motor behavior.
    Kretschmer BD; Goiny M; Herrera-Marschitz M
    J Neurochem; 2000 May; 74(5):2049-57. PubMed ID: 10800948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.